514 related articles for article (PubMed ID: 31153371)
1. Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression.
Zhang PF; Wei CY; Huang XY; Peng R; Yang X; Lu JC; Zhang C; Gao C; Cai JB; Gao PT; Gao DM; Shi GM; Ke AW; Fan J
Mol Cancer; 2019 Jun; 18(1):105. PubMed ID: 31153371
[TBL] [Abstract][Full Text] [Related]
2. m
Liu H; Jiang Y; Lu J; Peng C; Ling Z; Chen Y; Chen D; Tong R; Zheng S; Wu J
Epigenetics; 2023 Dec; 18(1):2204772. PubMed ID: 37092305
[No Abstract] [Full Text] [Related]
3. CircCPSF6 promotes hepatocellular carcinoma cancer progression by regulating MAP4K4 through sponging miR-145-5p.
Lu F; Gao J; Luo Y; Jin WL; Wang H; Li CX; Li X
Mol Cell Probes; 2023 Oct; 71():101920. PubMed ID: 37442529
[TBL] [Abstract][Full Text] [Related]
4. CircFAM114A2 inhibits the progression of hepatocellular carcinoma via miR-630/HHIP axis.
Lai M; Li D; Liu M; Zhang R; Wang L; Peng W; Xu H; Wu S; Liang S; Gu Y; Nan A; Zeng X
Cancer Med; 2023 Jun; 12(11):12553-12568. PubMed ID: 37039160
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circDLG1 contributes to HCC progression by regulating the miR-141-3p/WTAP axis.
Wang Q; Yu W; Wang T; Huang C
Funct Integr Genomics; 2023 May; 23(2):179. PubMed ID: 37227531
[TBL] [Abstract][Full Text] [Related]
6. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.
Du A; Li S; Zhou Y; Disoma C; Liao Y; Zhang Y; Chen Z; Yang Q; Liu P; Liu S; Dong Z; Razzaq A; Tao S; Chen X; Liu Y; Xu L; Zhang Q; Li S; Peng J; Xia Z
Mol Cancer; 2022 May; 21(1):109. PubMed ID: 35524319
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of circZNF720 Inhibits Hepatocellular Carcinoma Progression by Regulating miR-421/MAPK9.
Yang F; Zhuang Z; Liu C; Li F; Zhou J
Mol Biotechnol; 2024 May; 66(5):1165-1173. PubMed ID: 38159171
[TBL] [Abstract][Full Text] [Related]
8. The novel circular RNA HIPK3 accelerates the proliferation and invasion of hepatocellular carcinoma cells by sponging the micro RNA-124 or micro RNA-506/pyruvate dehydrogenase kinase 2 axis.
Yu Q; Chen W; Li Y; He J; Wang Y; Yang S; Zhou J
Bioengineered; 2022 Mar; 13(3):4717-4729. PubMed ID: 35212603
[TBL] [Abstract][Full Text] [Related]
9. EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway.
Liu Y; Song J; Zhang H; Liao Z; Liu F; Su C; Wang W; Han M; Zhang L; Zhu H; Zhang Z; Liang H; Zhang L; Zhang B; Chen X
J Exp Clin Cancer Res; 2022 May; 41(1):164. PubMed ID: 35509064
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of circPTTG1IP induces hepatocellular carcinoma development via miR-16-5p/RNF125/JAK1 axis.
Peng R; Cao J; Su BB; Bai XS; Jin X; Wang AQ; Wang Q; Liu RJ; Jiang GQ; Jin SJ; Zhang C; Bai DS
Cancer Lett; 2022 Sep; 543():215778. PubMed ID: 35710093
[TBL] [Abstract][Full Text] [Related]
11. CircMYBL2 facilitates hepatocellular carcinoma progression by regulating E2F1 expression.
Yi J; Li B; Yin X; Liu L; Song C; Zhao Y; Cai M; Tang H; Chen D; Lyu N
Oncol Res; 2024; 32(6):1129-1139. PubMed ID: 38827325
[TBL] [Abstract][Full Text] [Related]
12. ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways.
Yao Z; Luo J; Hu K; Lin J; Huang H; Wang Q; Zhang P; Xiong Z; He C; Huang Z; Liu B; Yang Y
Mol Oncol; 2017 Apr; 11(4):422-437. PubMed ID: 28211215
[TBL] [Abstract][Full Text] [Related]
13. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
[TBL] [Abstract][Full Text] [Related]
14. Hepatic stellate cell exosome-derived circWDR25 promotes the progression of hepatocellular carcinoma via the miRNA-4474-3P-ALOX-15 and EMT axes.
Liu L; Liao R; Wu Z; Du C; You Y; Que K; Duan Y; Yin K; Ye W
Biosci Trends; 2022 Sep; 16(4):267-281. PubMed ID: 35934785
[TBL] [Abstract][Full Text] [Related]
15. CircFOXK2 promotes hepatocellular carcinoma progression and leads to a poor clinical prognosis via regulating the Warburg effect.
Zheng J; Yan X; Lu T; Song W; Li Y; Liang J; Zhang J; Cai J; Sui X; Xiao J; Chen H; Chen G; Zhang Q; Liu Y; Yang Y; Zheng K; Pan Z
J Exp Clin Cancer Res; 2023 Mar; 42(1):63. PubMed ID: 36922872
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma.
Huang XY; Huang ZL; Xu YH; Zheng Q; Chen Z; Song W; Zhou J; Tang ZY; Huang XY
Sci Rep; 2017 Jul; 7(1):5428. PubMed ID: 28710406
[TBL] [Abstract][Full Text] [Related]
17. CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ.
Hao X; Zhang Y; Shi X; Liu H; Zheng Z; Han G; Rong D; Zhang C; Tang W; Wang X
J Exp Clin Cancer Res; 2022 Sep; 41(1):281. PubMed ID: 36131287
[TBL] [Abstract][Full Text] [Related]
18. N
Lu J; Ru J; Chen Y; Ling Z; Liu H; Ding B; Jiang Y; Ma J; Zhang D; Ge J; Li Y; Sun F; Chen D; Zheng S; Wu J
Clin Transl Med; 2023 Oct; 13(10):e1451. PubMed ID: 37877357
[TBL] [Abstract][Full Text] [Related]
19. circRERE regulates the expression of GBX2 through miR-1299 and ZC3H13/N
Lin YH; Zhang BY; Chen ZS
J Biosci; 2022; 47():. PubMed ID: 36222159
[TBL] [Abstract][Full Text] [Related]
20. circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinoma.
Xu L; Wang P; Li L; Li L; Huang Y; Zhang Y; Zheng X; Yi P; Zhang M; Xu M
Mol Cancer; 2023 Oct; 22(1):174. PubMed ID: 37884951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
